Sartorius Stedim Biotech S.A.'s AGM passed the resolution to pay dividends of €1.30 net per share for fiscal 2014, up from €1.20 a year earlier. The total profit distributed will therefore rise from €18.4 million to €20.0 million.

The AGM elected new non-executive members to the Board of Directors: Anne Marie Graffin, Managing Director of SMAG Consulting SARL, and Susan Dexter, Principal Consultant of the Latham Biopharm Group. As a result, the number of Board members has increased from eight to ten. In addition, Oscar-Werner Reif's term on the Board was renewed following his initial appointment in 2009. As Executive Vice President, he also manages the Group's global Research & Development unit.